Beam Therapeutics Inc.
NASDAQ:BEAMBiotechnology
Healthcare
$20.94 +1.46%
+$0.48 today
- Market cap
- $2.17B
- Beta
- 2.20
- P/E (TTM)
- -52.3
- EPS (TTM)
- -$0.63
52W Low $15.60High $36.44
Volume 4.21M
Average 2.11M
Balance Sheet
Inspect the capital base behind the business.
Assets
$1.48B
FY 2025 · Annual
+34.2% YoYLiabilities
$242.82M
FY 2025 · Annual
-34.4% YoYEquity
$1.24B
FY 2025 · Annual
+68.8% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 559.99M | 232.77M | 435.9M | 281.97M | 294.94M |
| Short-term Investments | 405.65M | 845.37M | 753.98M | 568.77M | 950.27M |
| Net Receivables | 300M | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 14.76M | 21.17M | 27.41M | 0 |
| Total Current Assets | 1.27B | 1.09B | 1.21B | 878.15M | 1.27B |
| Property, Plant & Equipment (Net) | 186.98M | 234.13M | 237.81M | 216.28M | 205.18M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 6.68M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 14.47M | 14.69M | 10.87M | 9.4M | 634K |
| Total Non-current Assets | 201.45M | 248.82M | 248.67M | 225.68M | 212.49M |
| Total Assets | 1.47B | 1.34B | 1.46B | 1.1B | 1.48B |
| Account Payables | 7.47M | 9.03M | 1.62M | 3.87M | 10.23M |
| Short-term Debt | 2.29M | 0 | 0 | 0 | 14.36M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 86.27M | 135.97M | 68.71M | 108.86M | 6.66M |
| Other Current Liabilities | 60.83M | 49.68M | 100.69M | 19.74M | 36.34M |
| Total Current Liabilities | 213.44M | 223.6M | 205.57M | 182.07M | 96.94M |
| Long-term Debt | 3.01M | 0 | 0 | 0 | 139.76M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 262.3M | 202.18M | 109.89M | 33.22M | 0 |
| Other Non-current Liabilities | 34.16M | 13.84M | 3.02M | 7.04M | (133.63M) |
| Total Non-current Liabilities | 434.28M | 384.65M | 272.82M | 188.21M | 145.88M |
| Total Liabilities | 647.72M | 608.24M | 478.39M | 370.28M | 242.82M |
| Common Stock | 684K | 712K | 816K | 836K | 1.02M |
| Retained Earnings | (768.27M) | (1.06B) | (1.19B) | (1.57B) | (1.64B) |
| Accumulated OCI | (50K) | (2.43M) | 604K | 679K | 1.11M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 826.74M | 733.47M | 981.33M | 733.55M | 1.24B |
| Total Debt | 147.64M | 179.01M | 172.69M | 161.43M | 293.88M |
| Net Debt | (412.35M) | (53.76M) | (263.21M) | (120.54M) | (1.06M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $219.8M |
| Short-term Investments | $933.1M |
| Other Current | $25.7M |
| Total Current Assets | $1.2B |
| PP&E (Net) | $193.2M |
| Other Non-current | $14.6M |
| Total Non-current Assets | $207.8M |
| Total Assets | $1.4B |
Analysis
Selected assets total $1.4B for Latest. The largest visible component is Short-term Investments at $933.1M, about 67.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 10-Q | Quarterly report | Nov 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 16, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 2, 2026 |
How much cash does BEAM have?
Beam Therapeutics Inc. (BEAM) reported $294.94M in cash and equivalents in fiscal 2025.
How much debt does BEAM carry?
Beam Therapeutics Inc. (BEAM) reported $293.88M of total debt, with net debt of -$1.06M.
Continue the stock analysis
Jump to another research area for this company.